Results 101 to 110 of about 2,144 (203)

Omadacycline successfully treated severe Legionella pneumonia after moxifloxacin treatment failure: Case series

open access: yesFrontiers in Pharmacology
Legionella is a significant pathogen responsible for community-acquired pneumonia and, less commonly, for hospital-acquired pneumonia. Legionella pneumophila, the most prevalent species within the Legionella genus, accounts for 80%–90% of human ...
Biyun Li   +7 more
doaj   +1 more source

The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome

open access: yesAntibiotics, 2016
Omadacycline is an aminomethylcycline antibiotic with potent activity against many Gram-positive and Gram-negative pathogens, including strains carrying the major efflux and ribosome protection resistance determinants. This makes it a promising candidate
Corina G. Heidrich   +6 more
doaj   +1 more source

Fecal Pharmacokinetics and Gut Microbiome Effects of oral Omadacycline Versus Vancomycin in Healthy Volunteers [PDF]

open access: yes
BACKGROUND: Clostridioides difficile infection (CDI) is a common healthcare-associated infection with limited treatment options. Omadacycline, an aminomethylcycline tetracycline, has potent in vitro activity against C difficile and a low propensity to ...
Agyapong, Samantha   +11 more
core   +1 more source

The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation [PDF]

open access: yes
The history of clinical resistance to tetracycline antibiotics is characterized by cycles whereby the deployment of a new generation of drug molecules is quickly followed by the discovery of a new mechanism of resistance. This suggests mechanism-specific
Blake, Kevin S   +6 more
core   +2 more sources

Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety

open access: yesInfectious Diseases and Therapy
Introduction The efficacy and safety of omadacycline have been primarily documented through Phase III clinical trials; however, there are limited data from real-world clinical settings.
Weiwen Gao   +7 more
doaj   +1 more source

Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Multiple Organ Failure: A Case Report

open access: yesInfection and Drug Resistance, 2022
Changquan Fang,1,* Limin Xu,2,* Jiarong Tan,1 Hongyi Tan,1 Junhong Lin,1 Ziwen Zhao3 1Department of Pulmonary and Critical Care Medicine, Huizhou Central People’s Hospital, Huizhou, Guangdong Province, Peoples’ Republic of China; 2Department of ...
Fang C   +5 more
doaj  

Case Report: Deep sternal wound infection caused by Mycoplasma hominis after cardiac surgery [PDF]

open access: yes
Deep sternal wound infection (DSWI) caused by Mycoplasma hominis after cardiac surgery is very rare and easily overlooked. This paper reports the case of a patient with DSWI after cardiac surgery. The patient had an unexplained fever postoperatively.
Lijun Chen   +3 more
core   +1 more source

Emergence of plasmid-borne tet(X4) resistance gene in clinical isolate of eravacycline- and omadacycline-resistant Klebsiella pneumoniae ST485

open access: yesMicrobiology Spectrum
Omadacycline and eravacycline are gradually being used as new tetracycline antibiotics for the clinical treatment of Gram-negative pathogens. Affected by various tetracycline-inactivating enzymes, there have been reports of resistance to eravacycline and
Xiaojing Liu   +12 more
doaj   +1 more source

Omadacycline for the treatment of severe pneumonia caused by Chlamydia psittaci complicated with acute respiratory distress syndrome during the COVID-19 pandemic

open access: yesFrontiers in Medicine
IntroductionChlamydia psittaci infection in humans is a rare cause that mainly present as community-acquired pneumonia. Severe Chlamydia psittaci pneumonia can lead to acute respiratory distress syndrome (ARDS), septic shock, or multiple organ ...
Dao-Xin Wang   +7 more
doaj   +1 more source

Susceptibility of multidrug-resistant Escherichia coli and Klebsiella pneumoniae to oral antibiotics in Australia

open access: yesJournal of Global Antimicrobial Resistance
: Objectives: In Australia, resistance to β-lactam-class antibiotics in Enterobacterales has increased. This study aimed to identify potential oral treatments for these multidrug-resistant infections by investigating four β-lactam (mecillinam, tebipenem,
Bethany Rachel O'Neill   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy